DEF 14A Filing

Company

Eton Pharmaceuticals, Inc.

Filed

April 28, 2022

Period of Report

April 28, 2022

Accession Number

0001493152-22-011427

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →